SLC19A1 and glioblastoma: Upon stratification, we observed that patients with high SLC19A1 expression had poorer prognosis in the GBM group (Supplementary Figure S2C), whereas there was no significant difference between the high and low SLC19A1 expression groups in LGG patients (Supplementary Figure S2D).